Table 1. Neutralizing antibody titers and anti-RVFV total IgG adjusted Sum_OD ELISA results of plasma from vaccinated and control animals.

Inoculum	rZH501-ΔNSs			rZH501-ΔNSs-ΔNSm			Sham Inoculated Controls
	Mean PRNT50 ± STDEV	Mean PRNT80 ± STDEV	Anti-RVFV IgG mean SumOD ± STDEV	Mean PRNT50 ± STDEV	Mean PRNT80 ± STDEV	Anti-RVFV IgG mean SumOD ± STDEV	Mean PRNT50 ± STDEV	Mean PRNT80 ± STDEV	Anti-RVFV IgG mean SumOD ± STDEV
Day 7 post-vaccination	1:867 ± 393	1:<400 ± 0	0.004 ± 0.006	1:<400 ± 0	1:<400 ± 0	-0.005 ± 0.0477	1:<400 ± 0	1:<400 ± 0	0.008 ± 0.023
Day 14 post-vaccination	1:23,467 ± 14,964	1:3,533 ± 4,709	0.111 ± 0.105	1:10,933 ± 4,572	1:933 ± 547	0.0741 ± 0.045	1:<400 ± 0	1:<400 ± 0	-0.002 ± 0.013
Day 21 post-vaccination	1:59,733 ± 34,976	1:8,267 ± 9,407	0.382 ± 0.125	1:26,667 ± 20,001	1:6,400 ± 3,505	0.258 ± 0.193	1:<400 ± 0	1:<400 ± 0	-0.003 ± 0.007
Day 28 post-vaccination	1:29,867 ± 17,488	1:13,867 ± 6,292	0.689 ± 0.168	1:10,733 ± 8,647	1:3,000 ± 2,814	0.384 ± 0.225	1:<400 ± 0	1:<400 ± 0	0.009 ± 0.004
Day 35 post-vaccination	1:25,707 ± 15,989	1:7,333 ± 9,253	1.052 ± 0.289	1:10,667 ± 8,507	1:1,867 ± 2,286	0.749 ± 0.492	1:<400 ± 0	1:<400 ± 0	0.003 ± 0.023
Day 7 post-challenge	1:56,533 ± 39,331	1:15,200 ± 9,149	1.757 ± 0.459	1:34,133 ± 19,271	1:10,133 ± 4,253	1.553 ± 0.717	1:3,360 ± 5,311	1:800 ± 490	0.001 ± 0.007
Day 14 post-challenge	1:90,667 ± 70,390	1:32,533 ± 21,648	2.011 ± 0.748	1:72,533 ± 65,601	1:16,000 ± 7,838	1.659 ± 0.691	1:71,680 ± 28,043	1: 8,640 ± 5,724	0.378 ± 0.307
Day 21 post-challenge	1:78,933 ± 73,493	1:21,333 ± 17,013	1.482 ± 0.656	1:59,733 ± 71,802	1:17,067 ± 17,013	1.338 ± 0.675	1:184,320 ± 133,513	1:46,080 ± 33,378	1.294 ± 0.594
Day 28 post-challenge	1:36,267 ± 17,013	1: 9,067 ± 4,253	1.867 ± 1.013	1:14,933 ± 5,226	1:4,267 ± 1,652	1.374 ± 0.609	1:307,202 ± 289,635	1:97,280 ± 68,692	1.232 ± 0.417